Pure Financial Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53K Buy
11,001
+127
+1% +$767 ﹤0.01% 633
2026
Q1
$67K Sell
10,874
-69
-0.6% -$573 ﹤0.01% 566
2025
Q4
$114K Buy
10,943
+64
+0.6% +$642 ﹤0.01% 530
2025
Q3
$97.8K Buy
10,879
+20
+0.2% +$176 ﹤0.01% 491
2025
Q2
$141K Buy
10,859
+50
+0.5% +$752 ﹤0.01% 462
2025
Q1
$273K Sell
10,809
-3,603
-25% -$107K 0.01% 328
2024
Q4
$495K Hold
14,412
0.01% 218
2024
Q3
$712K Hold
14,412
0.02% 181
2024
Q2
$867K Sell
14,412
-3,980
-22% -$227K 0.02% 154
2024
Q1
$949K Buy
+18,392
New +$903K 0.03% 148

Other funds holding RXST

Pure Financial Advisors's RXST Position: Q2 2026 in Review

Pure Financial Advisors increased its RxSight (RXST) stake by 1.2% in Q2 2026, buying an estimated $767 and bringing the position to 11,001 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #633.

Pure Financial Advisors first reported a position in RXST in Q1 2024 and has held it in 10 quarters since. The position peaked at $949K in Q1 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Pure Financial Advisors held 11,001 shares of RxSight worth $53K as of Q2 2026.
  • Pure Financial Advisors bought 127 RxSight shares in Q2 2026, an estimated $767.
  • RxSight made up ﹤0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #633 holding.
  • Pure Financial Advisors first reported a position in RxSight in Q1 2024 and has held it in 10 quarters since.
  • Pure Financial Advisors's RxSight position peaked at $949K in Q1 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.